Check-Cap Ltd. Stock

Equities

CHEK

IL0011336851

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-05-24 pm EDT 5-day change 1st Jan Change
2.27 USD 0.00% Intraday chart for Check-Cap Ltd. +3.89% +9.13%
Sales 2022 - Sales 2023 - Capitalization 12.17M
Net income 2022 -19M Net income 2023 -17M EV / Sales 2022 -
Net cash position 2022 40.74M Net cash position 2023 24.76M EV / Sales 2023 -
P/E ratio 2022
-0.65 x
P/E ratio 2023
-0.69 x
Employees 85
Yield 2022 *
-
Yield 2023
-
Free-Float 74.84%
More Fundamentals * Assessed data
Dynamic Chart
1 week+3.89%
Current month+2.02%
1 month+2.25%
3 months+0.44%
6 months-34.77%
Current year+9.13%
More quotes
1 week
2.15
Extreme 2.15
2.27
1 month
2.00
Extreme 2
2.30
Current year
1.78
Extreme 1.78
3.45
1 year
1.41
Extreme 1.41
4.63
3 years
1.22
Extreme 1.22
38.18
5 years
1.22
Extreme 1.22
89.80
10 years
1.22
Extreme 1.22
1 427.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 Mar. 16
Founder 63 04-12-31
Director of Finance/CFO 54 Mar. 05
Members of the board TitleAgeSince
Founder 63 04-12-31
More insiders
Date Price Change Volume
24-05-24 2.27 0.00% 9,716
24-05-23 2.27 +2.25% 2,633
24-05-22 2.22 +0.23% 8,282
24-05-21 2.215 +1.61% 5,310
24-05-20 2.18 -0.23% 2,066

Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT

More quotes
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
More about the company